Skip to main content
Premium Trial:

Request an Annual Quote

B-Bridge, Pointilliste Align to Market Antibody Array Technology

NEW YORK, March 17 (GenomeWeb News) - B-Bridge International of Sunnyvale, Calif., and Pointilliste of Mountain View, Calif., have expanded their partnership to commercialize Pointilliste's new custom antibody array technology platform, the firms said this week.

The Universal Canvas brand technology mutiplexes nine ELISA assays on a 96-well plate and uses standard imaging systems. The companies, which are also collaborating to market another Pontilliste array product, said the new technology will be available within weeks.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more